Thank you for your participation in the IDEAYA Biosciences Medical Ad Board to take place at the DoubleTree by Hilton Hotel Philadelphia Center City in Philadelphia, PA on Thursday, September 17, 2026, from 11:00 am to 3:00 pm ET.
This program will bring together a select group of experts to share insights, discuss key considerations, and provide strategic guidance to help inform ongoing medical and scientific planning. Your perspective and expertise are highly valued, and we look forward to a productive and engaging discussion.
The objectives of the meeting are:
- Gather insights on OptimUM‑01 and ‑02 findings, including key efficacy and safety outcomes
- Assess where darovasertib + crizotinib may fit within the evolving mUM treatment paradigm in HLA‑A*02:01–positive and –negative populations
- Identify key educational topics and strategies to familiarize academic and community HCPs with darovasertib + crizotinib
- Gather perspectives on future clinical trial opportunities in mUM
Please use this site to confirm your registration, get information and support on travel, and review the meeting details.